Characterization of MicroRNA Expression Profiles in Patients with Giant Cell Tumor

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Giant cell tumors (GCTs) are bone-destructive neoplasms where osteoclasts mediate bone resorption.
• MicroRNAs (miRNAs) play a critical role in cell fate and tumorigenesis, suggesting their potential in regulating osteoclastogenesis.
• A specific miRNA profile for GCTs has been lacking, necessitating further investigation.

Purpose of the Study:

• To investigate the expression of osteoclastogenesis-related miRNAs in Chinese patients diagnosed with GCTs.
• To identify potential miRNA biomarkers for GCTs and their correlation with tumor grade and bone resorption.

Main Methods:

• Quantitative reverse transcription polymerase chain reaction (PCR) was used to assess miRNA and mRNA expression in GCT samples and a control group.
• Patients were categorized based on Campanacci grading, and histological examination confirmed diagnoses.
• Expression levels of osteoclastogenesis-related genes and 20 miRNAs were analyzed.

Main Results:

• Higher Campanacci grades in GCTs correlated with increased osteoclast number and size.
• Osteoclastogenesis-related mRNAs (cathepsin K, tartrate-resistant acid phosphatase, matrix metalloproteinase9) were significantly elevated in GCTs.
• Six miRNAs showed significantly lower expression in GCTs compared to controls, with hsa-mir-16-5p and hsa-let-7a-5p expression correlating with tumor grade.

Conclusions:

• Six novel miRNA markers demonstrate clinical utility for GCTs.
• The expression levels of hsa-mir-16-5p and hsa-let-7a-5p may serve as indicators of bone resorption severity in GCT patients.
• These findings contribute to understanding GCT pathogenesis and offer potential diagnostic or prognostic tools.